Unknown

Dataset Information

0

Patient-derived enteroids provide a platform for the development of therapeutic approaches in microvillus inclusion disease.


ABSTRACT: Microvillus inclusion disease (MVID), caused by loss-of-function mutations in the motor protein myosin Vb (MYO5B), is a severe infantile disease characterized by diarrhea, malabsorption, and acid/base instability, requiring intensive parenteral support for nutritional and fluid management. Human patient-derived enteroids represent a model for investigation of monogenic epithelial disorders but are a rare resource from MVID patients. We developed human enteroids with different loss-of function MYO5B variants and showed that they recapitulated the structural changes found in native MVID enterocytes. Multiplex immunofluorescence imaging of patient duodenal tissues revealed patient-specific changes in localization of brush border transporters. Functional analysis of electrolyte transport revealed profound loss of Na+/H+ exchange (NHE) activity in MVID patient enteroids with near-normal chloride secretion. The chloride channel-blocking antidiarrheal drug crofelemer dose-dependently inhibited agonist-mediated fluid secretion. MVID enteroids exhibited altered differentiation and maturation versus healthy enteroids. γ-Secretase inhibition with DAPT recovered apical brush border structure and functional Na+/H+ exchange activity in MVID enteroids. Transcriptomic analysis revealed potential pathways involved in the rescue of MVID cells including serum/glucocorticoid-regulated kinase 2 (SGK2) and NHE regulatory factor 3 (NHERF3). These results demonstrate the utility of patient-derived enteroids for developing therapeutic approaches to MVID.

SUBMITTER: Kalashyan M 

PROVIDER: S-EPMC10575727 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Patient-derived enteroids provide a platform for the development of therapeutic approaches in microvillus inclusion disease.

Kalashyan Meri M   Raghunathan Krishnan K   Oller Haley H   Bayer Marie-Theres MT   Jimenez Lissette L   Roland Joseph T JT   Kolobova Elena E   Hagen Susan J SJ   Goldsmith Jeffrey D JD   Shub Mitchell D MD   Goldenring James R JR   Kaji Izumi I   Thiagarajah Jay R JR  

The Journal of clinical investigation 20231016 20


Microvillus inclusion disease (MVID), caused by loss-of-function mutations in the motor protein myosin Vb (MYO5B), is a severe infantile disease characterized by diarrhea, malabsorption, and acid/base instability, requiring intensive parenteral support for nutritional and fluid management. Human patient-derived enteroids represent a model for investigation of monogenic epithelial disorders but are a rare resource from MVID patients. We developed human enteroids with different loss-of function MY  ...[more]

Similar Datasets

2023-08-16 | GSE240928 | GEO
| S-EPMC9900906 | biostudies-literature
| PRJNA1005900 | ENA
| S-EPMC4733813 | biostudies-other
| S-EPMC5731099 | biostudies-literature
| S-EPMC4511872 | biostudies-literature
| S-EPMC7794843 | biostudies-literature
| S-EPMC5797493 | biostudies-literature
| S-EPMC4071383 | biostudies-literature
| S-EPMC6029049 | biostudies-literature